{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:34:27Z","timestamp":1792802067567,"version":"4.5.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Data Research UK","award":["CFC1007"],"award-info":[{"award-number":["CFC1007"]}],"id":[{"id":"https:\/\/ror.org\/04rtjaj74","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MR\/L01341X\/1; MR\/ S019669\/1"],"award-info":[{"award-number":["MR\/L01341X\/1; MR\/ S019669\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Imperial College British Heart Foundation Centre for Research Excellence","award":["RE\/18\/4\/34215"],"award-info":[{"award-number":["RE\/18\/4\/34215"]}],"id":[{"id":"https:\/\/ror.org\/02wdwnk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"UK Dementia Research Institute at Imperial College London","award":["MC_PC_17114"],"award-info":[{"award-number":["MC_PC_17114"]}],"id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol\/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004141","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T13:24:26Z","timestamp":1672320266000},"page":"e1004141","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-8102","authenticated-orcid":true,"given":"Loukas","family":"Zagkos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-5684","authenticated-orcid":true,"given":"Marie-Joe","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-4873","authenticated-orcid":true,"given":"Rui","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-7078","authenticated-orcid":true,"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1253-7556","authenticated-orcid":true,"given":"Fotios","family":"Koskeridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-5516","authenticated-orcid":true,"given":"Fotios","family":"Drenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-579X","authenticated-orcid":true,"given":"Georgios","family":"Markozannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-5684","authenticated-orcid":true,"given":"Paul","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Tsilidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-016X","authenticated-orcid":true,"given":"Abbas","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-9328","authenticated-orcid":true,"given":"Ioanna","family":"Tzoulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"pmed.1004141.ref001","author":"K Nagy","year":"2017","journal-title":"Importance of Fatty Acids in Physiopathology of Human Body"},{"issue":"3","key":"pmed.1004141.ref002","doi-asserted-by":"crossref","first-page":"293S","DOI":"10.3945\/an.114.006940","article-title":"The science of fatty acids and inflammation","volume":"6","author":"KL Fritsche","year":"2015","journal-title":"Adv Nutr"},{"issue":"Suppl 1","key":"pmed.1004141.ref003","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ejphar.2011.05.085","article-title":"Fatty acids and inflammation: the cutting edge between food and pharma","volume":"668","author":"PC Calder","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"pmed.1004141.ref004","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/heartjnl-2020-316780","article-title":"Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis","volume":"107","author":"EC Rizos","year":"2021","journal-title":"Heart"},{"issue":"4","key":"pmed.1004141.ref005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.clnu.2022.02.022","article-title":"Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events.","volume":"41","author":"G Markozannes","year":"2022","journal-title":"Clin Nutr."},{"issue":"4","key":"pmed.1004141.ref006","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/eb-2012-100960","article-title":"Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease.","volume":"18","author":"C. von Schacky","year":"2013","journal-title":"Evid Based Med"},{"issue":"1","key":"pmed.1004141.ref007","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mayocp.2016.10.018","article-title":"A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk","volume":"92","author":"DD Alexander","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"pmed.1004141.ref008","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-018-0740-x","article-title":"Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials","volume":"17","author":"LL O\u2019Mahoney","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"78","key":"pmed.1004141.ref009","first-page":"1","article-title":"Use of complementary health approaches among children aged 4\u201317 years in the United States: National Health Interview Survey.","volume":"10","author":"CT Black LI","year":"2015","journal-title":"Natl Health Stat Rep."},{"key":"pmed.1004141.ref010","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2015-3723","article-title":"The use of complementary health approaches among US cancer survivors","volume":"75","author":"TC Clarke","year":"2015","journal-title":"Cancer Res"},{"issue":"7","key":"pmed.1004141.ref011","doi-asserted-by":"crossref","first-page":"e1002193","DOI":"10.1371\/journal.pgen.1002193","article-title":"Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium.","volume":"7","author":"RN Lemaitre","year":"2011","journal-title":"PLoS Genet."},{"issue":"3","key":"pmed.1004141.ref012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCGENETICS.113.000208","article-title":"Genome-Wide Association Study of Plasma N6 Polyunsaturated Fatty Acids Within the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium.","volume":"7","author":"WH Guan","year":"2014","journal-title":"Circ-Cardiovasc Gene"},{"issue":"2","key":"pmed.1004141.ref013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCGENETICS.112.964619","article-title":"Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.","volume":"6","author":"JH Wu","year":"2013","journal-title":"Circ Cardiovasc Genet."},{"issue":"6","key":"pmed.1004141.ref014","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites","volume":"46","author":"SY Shin","year":"2014","journal-title":"Nat Genet"},{"key":"pmed.1004141.ref015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.plefa.2014.11.007","article-title":"A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study","volume":"94","author":"NL Tintle","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"pmed.1004141.ref016","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"C Sudlow","year":"2015","journal-title":"PLoS Med."},{"issue":"7726","key":"pmed.1004141.ref017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"C Bycroft","year":"2018","journal-title":"Nature"},{"key":"pmed.1004141.ref018","article-title":"The MRC IEU OpenGWAS data infrastructure.","author":"B Elsworth","year":"2020","journal-title":"BioRxiv [preprint]."},{"key":"pmed.1004141.ref019","article-title":"PLINK: a toolset for whole-genome association and population-based linkage analysis","author":"SNB Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"pmed.1004141.ref020","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.","volume":"7","author":"J Kettunen","year":"2016","journal-title":"Nat Commun."},{"issue":"20","key":"pmed.1004141.ref021","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","article-title":"Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry","volume":"27","author":"L Yengo","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"10","key":"pmed.1004141.ref022","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"M Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"pmed.1004141.ref023","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"JC Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"12","key":"pmed.1004141.ref024","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2337\/db10-0502","article-title":"Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways.","volume":"59","author":"N Soranzo","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"pmed.1004141.ref025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.2897","article-title":"Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility","volume":"46","author":"A Mahajan","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"pmed.1004141.ref026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate\u2014a Practical and Powerful Approach to Multiple Testing.","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"7","key":"pmed.1004141.ref027","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data","volume":"37","author":"S Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"2","key":"pmed.1004141.ref028","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"J Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pmed.1004141.ref029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator","volume":"40","author":"J Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"5","key":"pmed.1004141.ref030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"M Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"pmed.1004141.ref031","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/aje\/kwv017","article-title":"Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects","volume":"181","author":"S Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pmed.1004141.ref032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-019-13870-3","article-title":"Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization.","volume":"11","author":"V Zuber","year":"2020","journal-title":"Nat Commun."},{"issue":"3","key":"pmed.1004141.ref033","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.","volume":"48","author":"E Sanderson","year":"2019","journal-title":"Int J Epidemiol"},{"key":"pmed.1004141.ref034","volume-title":"R: A language and environment for statistical computing","author":"Team RC.","year":"2020"},{"issue":"16","key":"pmed.1004141.ref035","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment","volume":"30","author":"RJ Carroll","year":"2014","journal-title":"Bioinformatics"},{"key":"pmed.1004141.ref036","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"G Hemani","year":"2018","journal-title":"Elife"},{"key":"pmed.1004141.ref037","unstructured":"Gordon M, Lumley, T., Gordon, M. M. R Package \u2018forestplot\u2019. Advanced Forest Plot Using \u2018grid\u2019 Graphics. 2016."},{"issue":"3","key":"pmed.1004141.ref038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.3211","article-title":"LD Score regression distinguishes confounding from polygenicity in genome-wide association studies","volume":"47","author":"Schizophrenia Working Group of the Psychiatric Genomics C","year":"2015","journal-title":"Nat Genet"},{"issue":"7","key":"pmed.1004141.ref039","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-141-7-200410050-00007","article-title":"The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men\u2014A prospective cohort study","volume":"141","author":"CJ Tsai","year":"2004","journal-title":"Ann Intern Med"},{"issue":"4","key":"pmed.1004141.ref040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.1840160418","article-title":"Dietary N-3 Polyunsaturated Fatty-Acids Decrease Biliary Cholesterol Saturation in Gallstone Disease","volume":"16","author":"F Berr","year":"1992","journal-title":"Hepatology"},{"issue":"11","key":"pmed.1004141.ref041","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1440-1746.2012.07227.x","article-title":"N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice","volume":"27","author":"JK Kim","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"pmed.1004141.ref042","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ejcn.2013.197","article-title":"Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management.","volume":"67","author":"B Gray","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"pmed.1004141.ref043","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clnesp.2021.04.023","article-title":"Effects of omega-3 supplementation on body weight and body fat mass: A systematic review.","volume":"44","author":"FM Delpino","year":"2021","journal-title":"Clinical Nutrition Espen"},{"key":"pmed.1004141.ref044","author":"EM Agency","year":"2019","journal-title":"EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack."},{"issue":"12","key":"pmed.1004141.ref045","first-page":"E673","article-title":"Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association","volume":"140","author":"AC Skulas-Ray","year":"2019","journal-title":"Circulation"},{"key":"pmed.1004141.ref046","article-title":"Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials","volume":"366","author":"TJ Brown","year":"2019","journal-title":"Bmj-Brit Med J"},{"issue":"3","key":"pmed.1004141.ref047","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/2279-042X.162356","article-title":"Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients","volume":"4","author":"AE Naini","year":"2015","journal-title":"J Res Pharm Pract"},{"issue":"7","key":"pmed.1004141.ref048","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5539\/gjhs.v8n7p18","article-title":"The Effect of Omega-3 Fatty Acids in Patients With Active Rheumatoid Arthritis Receiving DMARDs Therapy: Double-Blind Randomized Controlled Trial","volume":"8","author":"E Rajaei","year":"2015","journal-title":"Global J Health Sci"},{"issue":"11","key":"pmed.1004141.ref049","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112599","article-title":"Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.","volume":"11","author":"A Sekikawa","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"pmed.1004141.ref050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","article-title":"Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis","volume":"308","author":"EC Rizos","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"pmed.1004141.ref051","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02399-w","article-title":"Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using Mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants.","volume":"20","author":"MC Borges","year":"2022","journal-title":"BMC Med."},{"issue":"21","key":"pmed.1004141.ref052","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.","volume":"139","author":"M Marklund","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"pmed.1004141.ref053","article-title":"Omega-6 fats for the primary and secondary prevention of cardiovascular disease.","author":"L Hooper","year":"2018","journal-title":"Cochrane Db Syst Rev."}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T01:34:30Z","timestamp":1728610470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004141"}},"subtitle":[],"editor":[{"given":"Ronald C. W.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004141","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]}}}